Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 5Colorectal Neoplasms 5Neoplasms 4Breast Neoplasms 4Stomatitis 3Neoplasm Metastasis 3Adenoma 3Urologic Neoplasms 2Stomach Neoplasms 2Mucositis 2Insulin Resistance 2Head and Neck Neoplasms 2Vulvodynia 1Urologic Diseases 1Urolithiasis 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pain, Postoperative 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mobility Limitation 1Melanoma 1MRSA Colonization 1

Interventions

Bupivacaine 31Ropivacaine 19Dexmedetomidine 19Saline Solution 18Morphine 12Ketamine 12Sodium Chloride 10Pregabalin 9Lidocaine 9Acetaminophen 9Control Groups 7Injections, Epidural 5Gabapentin 4Epinephrine 4Dexamethasone 4Anesthetics, Local 4Anesthesia, General 4Analgesia, Patient-Controlled 4parecoxib 3oxycodone-acetaminophen 3Tea 3Midazolam 3Ketorolac 3Fentanyl 3Esketamine 3Dental Occlusion 3Vitamins 2Tramadol 2Surgical Procedures, Operative 2Sufentanil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain, Postoperative × Water × Clear all
NCT02522598 2016-09-29

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy

Vivozon, Inc.

Phase 2 Completed
38 enrolled

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡